IL6R and juvenile idiopathic arthritis: In our series (Appendix A, Table A1), other observed risk factors were juvenile rheumatoid arthritis under immunosuppressive treatment (methotrexate, prednisone, and an interleukin-6 receptor blocker) and Crohn’s disease (on a tumor necrosis factor-alpha blocker).